Recruiting
Phase 2

Allopregnanolone

Sponsor:

University of Arizona

Code:

NCT04838301

Conditions

Alzheimer Dementia

Late Onset Alzheimer Disease

Neurodegenerative Diseases

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Allopregnanolone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-22. This information was provided to ClinicalTrials.gov by University of Arizona on 2025-05-11.